Alteration of coagulation and fibrinolysis systems after multidrug anticancer therapy for lung cancer
- 31 December 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (9) , 1276-1281
- https://doi.org/10.1016/0959-8049(94)90172-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancerCancer, 1992
- Coagulation Abnormalities in Malignancy: A ReviewSeminars in Thrombosis and Hemostasis, 1992
- The influence of chemotherapy on plasma coagulation and fibrinolytic systems in lung cancer patientsCancer, 1989
- The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast CancerNew England Journal of Medicine, 1988
- Chemotherapy for breast cancer decreases plasma protein C and protein S.Journal of Clinical Oncology, 1988
- Monoclonal antibodies to discrete regions in alpha 2-plasmin inhibitorBlood, 1987
- Hypercoagulable state induced by cytostatic drugs in stage ii breast cancer patientsCancer, 1986
- Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimenCancer, 1984
- Activation of blood coagulation in cancer: Trousseau's syndrome revisitedBlood, 1983
- Raynaud's Phenomenon: A Common Toxicity After Combination Chemotherapy for Testicular CancerAnnals of Internal Medicine, 1981